Market status analysis and future competitive strategy of domestic pharmaceutical equipment industry

[ Market analysis of chemical machinery and equipment network ] The pharmaceutical equipment industry is the upstream of the pharmaceutical industry.
With the intensification of aging and the continuous upgrading of consumption, the rapid development of China's pharmaceutical industry over the years has led to the continuous expansion of the market scale of the pharmaceutical equipment industry.
The sales scale is expected to reach 100 billion yuan.
But in the face of opportunities, challenges often accompany them, and they need to be dealt with in order to achieve longer-term development.
Drawing lessons from the SWOT analysis method in strategic analysis, the author will conduct a comprehensive analysis of the internal and external conditions of the domestic pharmaceutical equipment industry in recent years, including analysis of strengths, weaknesses, opportunities (opportunities) and threats (Threats).
Comprehensive analysis and summary, exploring the company's future competitive strategy.

Strengths: Low price and easy maintenance
 

Compared with expensive imported pharmaceutical equipment, the price advantage of domestic equipment is obvious.
This is also the reason why many small and medium-sized pharmaceutical companies are willing to buy domestic equipment in the past.
At the same time, because the domestic pharmaceutical equipment manufacturers are located in the local area, they can be handled in a relatively timely manner in terms of maintenance and service.
There are no obstacles such as time difference, culture, and language, which provides convenient conditions for domestic pharmaceutical companies.
.

 

　　In addition, some of the more unique pharmaceutical production equipment, such as traditional Chinese medicine pharmaceutical equipment , are often better for domestic manufacturers, and the equipment built is more suitable for the characteristics of traditional Chinese medicine and meets the needs of domestic traditional Chinese medicine manufacturers.

 

　　Weaknesses: Low technical content and unstable performance
 

　　Although the domestic medicine machine is cheap and easy to maintain, it is still difficult to compare with imported equipment in terms of technical content, performance stability, appearance, and ease of operation.
Due to the lack of core technology, most of the domestically-made equipment is still mainly produced at low levels, so it is mainly targeted at the middle and low-end markets, and generally lacks competitiveness in the field.

 

　　In addition, domestic pharmaceutical equipment manufacturers have focused on single equipment manufacturing for a long time, and few manufacturers can provide a complete production line from preparation to end packaging, so they cannot provide users with more added value and services.

 

　　Opportunities: market demand is large, policy support
 

　　my country is a big country in the production of pharmaceuticals.
With the intensification of aging, the demand for pharmaceuticals will continue to grow.
In recent years, driven by policies such as medical insurance control fees and centralized drug procurement, the pharmaceutical industry is accelerating its transformation and upgrading, forcing pharmaceutical companies to transform from generic drugs to innovative drugs, and improve the R&D and industrialization capabilities of independently created drugs.
In this context, the industry generally believes that new demand will give rise to new opportunities, and the pharmaceutical equipment industry will usher in a golden period of development in the next few years.

 

　　Policies have also given a lot of support to the pharmaceutical equipment industry, such as the "Healthy China 2030" national strategy, "Made in China 2025", etc.
, pointing out some directions for the development and growth of the industry, including automation and intelligence.

 

　　Threats: Imported products are highly competitive and domestic products are homogenized
 

　　Facing my country's huge market space, foreign equipment manufacturers are constantly entering the market.
It can be found that they have frequently appeared in some pharmaceutical machinery product exhibitions in recent years.
At present, domestic pharmaceutical equipment companies are still facing the situation of "internal and external troubles".
On the one hand, they must deal with the competition of imported equipment, and on the other hand, they need to break the predicament of domestic homogeneous competition.

 

　　Future competitive strategy
 

　　Based on the above-mentioned internal and external conditions of the domestic pharmaceutical equipment industry, in the future, domestic pharmaceutical companies will need to work hard in at least a few areas, continue to give full play to their advantages, make up for shortcomings, and improve market competitiveness.

 

　　One is to increase independent innovation, by increasing R&D investment, cultivating more professional talents, and constantly breaking the core technical bottleneck of "stuck neck", so as to create more products with domestically produced original research and improve competitiveness.

 

　　Second, pharmaceutical companies should not “make cars behind closed doors”, but should always pay attention to market changes, maintain flexibility and speed of action, keep pace with the times, update and upgrade equipment and technology to meet new user needs, new requirements and industry trends.
Market demand.

 

　　Third, improve service quality.
Facing the fierce competition of product homogeneity, companies need to look for differentiated competitive strategies, such as creating new and different products or services provided by the company to form some distinctive competitive advantages.
In terms of services, companies should pay attention to both pre-sales and after-sales.

 

　　Fourth, the transformation towards the direction of chemistry.
According to the "In-Depth Market Research and Investment Strategy Recommendation Report for the Pharmaceutical Equipment Industry for 2020-2024" released by the New Sijie Industry Research Center, at present, domestic pharmaceutical equipment has basically achieved import substitution in the low-end market, but there is still a need for further progress in the market.
Strengthen the breakthrough.

 

　　Original Title: Market Status Analysis of Domestic Pharmaceutical Equipment Industry and Future Competitive Strategy